Researchers from the Danish Headache Center report chronic migraine, daily headache & prior treatment failures reduce erenumab efficacy for migraine. Older age linked to better outcomes. Severe phenotypes linked to delayed response. Please read at: buff.ly/teJLQH3 @hmru_cph